|
Geerard Beets How to Approach the MMR Deficient Patient with Locally Advanced Colon Cancer |
|
Geerard Beets Where Do We Stand with Lateral Compartment Lymphadenectomies |
|
Geerard Beets Where Does the Evidence Stand in Support & Against Non-operative Management Strategies |
|
Marylise Boutros Technical Considerations in the Treatment of Transverse Colon Cancers |
|
Carl Brown How to Manage the T2 Tumour Overtreatment Oncologically or Undertreatment Functionally |
|
Sean Cleary Oncologic & Technical Considerations with Stage IV Liver Disease |
|
Julio Garcia-Aguilar D3 Lymphadenectomy in Colon Cancer Where Does the Evidence Stand |
|
Faek Jamali Novel Therapies for Peritoneal Carcinomatosis HIPEC, PIPEC & Beyond |
|
Uqba Khan CtDNA & Systemic Options in the Adjuvant Treatment of Stage II & Stage III Colon Cancer To Escalate or De-Escalate, That is The Question |
|
Uqba Khan Immunotherapeutic Considerations Treating the MMR Deficient & Proficient Locally Advanced Rectal Cancer |
|
Gonzalo Sapisochin Unresectable Metastatic Disease Considerations & Outcomes in Transplant Oncology |